Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

April 1st 2020, Crypto Chartbook: You snooze you lose

You snooze you lose The required skill level to prosper trading is treading light footed. This is only possible with confidence. Confidence comes from a knowing. Knowing settles in after a long time of experience. However any professional can get shaken up, hence the sayi...
Korbinian Koller | April 1, 2020 |

Galantas Gold: operating and expanding Northern Ireland's first gold mine

Galantas Gold Corporation recently operated on their open pit gold mine in Northern Ireland. Continuing to mine, they have around two kilometres of underground development completed so far, and today I have the pleasure of speaking with the company CEO and Executive ...
Daniella Atkinson | December 20, 2022 |

Meet the Company Diving into the Cannabis 3.0 Market

The first and second waves of the cannabis market have come and gone, which has only prepared us for the cannabis 3.0 market and all the derivative products that come with it. Companies like Ayurcann Holdings Corp. ( CSE:AYUR , OTCQB:AYURF , Forum ) are...
Jocelyn Aspa | March 23, 2022 |

Let's Invest: Are you prepared for do-it-yourself investing?

In our fourth segment of our “Let’s Invest” series’ with Jean-Paul Bureaud, executive director of FAIR Canada , we stay on the self-investing side with DIY – do-it-yourself investing. Bureaud goes over the pros and co...
Coreena Robertson | June 11, 2024 |

Blacktop politics

Benjamin Franklin once said; “Out of adversity comes opportunity.” The adversity the United States now faces with the coronavirus pandemic is the worst national emergency the country has faced since World War II, more serious, far more deadly, than a...
Richard (Rick) Mills | April 3, 2020 |

Apogee Enterprises Shares Trade Up 12.5% on Q2 Earnings and Yearly Outlook

Shares of Apogee Enterprises are trading higher today after the commercial and architectural glass and framing company announced Q2/20 earnings and updated its estimates for the rest of the year. This morning commercial and architectural glass fabricator and window fr...
Streetwise Reports | September 18, 2019 |

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
Streetwise Reports | December 4, 2019 |

Biopharma to Test Immunity Activator in Advanced Solid Cancers

The company's plans for and approach to one of its most advanced drug candidates are discussed in an H.C. Wainwright & Co. report. In a Dec. 12 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) plans to ...
Streetwise Reports | December 19, 2019 |

Paratek Pharma Awarded $285 Million BARDA Contract to Combat Anthrax

Shares of Paratek Pharmaceuticals traded 40% higher today after the firm announced it was awarded a BARDA BioShield program contract valued at up to $285 million for NUZYRA used to treat anthrax. Late yesterday afternoon, biopharmaceutical company Paratek Pharmaceuti...
Streetwise Reports | December 20, 2019 |

U.S.-Based Biotech 'Growing into a Giant with AI'

How Moderna uses and benefits from digitization and artificial intelligence are described in a ROTH Capital Partners report. In a March 5 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that a site visit to Moderna Inc.'s (MRNA:NASDAQ) ...
Streetwise Reports | March 9, 2020 |
1 2 3 4 5 6 7 8 9 10 ...